---
title: Music and Adherence Home Programs Post Stroke
nct_id: NCT02906956
overall_status: COMPLETED
phase: EARLY_PHASE1
sponsor: Duquesne University
study_type: INTERVENTIONAL
primary_condition: Stroke
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT02906956.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT02906956"
ct_last_update_post_date: 2019-07-16
last_seen_at: "2026-05-12T06:22:57.385Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Music and Adherence Home Programs Post Stroke

**Official Title:** Music and Adherence in Upper Extremity Home Programs Post Stroke

**NCT ID:** [NCT02906956](https://clinicaltrials.gov/study/NCT02906956)

## Key Facts

- **Status:** COMPLETED
- **Phase:** EARLY_PHASE1
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 7
- **Lead Sponsor:** Duquesne University
- **Conditions:** Stroke
- **Start Date:** 2016-09
- **Completion Date:** 2017-08
- **CT.gov Last Update:** 2019-07-16

## Brief Summary

The purpose of this study is to explore whether adherence to upper extremity home programs changes when persons post stroke practice with preferred music.

## Eligibility

- **Minimum age:** 40 Years
- **Maximum age:** 85 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Ages 40-85
* Mild to Moderate hemiparesis as determined by a score of 21 to 50 on the FM- UE
* At least 6 months post stroke
* American English as primary language

Exclusion Criteria:

* Significant visual impairment as determined by "aphasia-friendly" and age appropriate screening
* Significant hearing impairment as determined by self-report
* Actively receiving occupational or physical therapy services for upper extremity motor recovery
* Severe auditory comprehension impairment such that they cannot understand one-step directions as indicated by a WAB-R score below 8/10 on Sequential Commands Subtest
* Sitting or standing blood pressure of 180/110 or HE \> 100 bpm
```

## Arms

- **Preferred Music Playlist** (EXPERIMENTAL) — All participants will have this phase twice in the protocol. See description in intervention section.

## Interventions

- **Preferred music playlist** (BEHAVIORAL) — Client will be instructed in a home program based on repetitive task practice principles and will complete this program with and without the use of a preferred music playlist during practice.

## Primary Outcomes

- **Number of sessions of practice** _(time frame: 4 weeks)_
- **Duration of sessions of practice** _(time frame: 4 weeks)_
- **Number of minutes of practice** _(time frame: 4 weeks)_

## Secondary Outcomes

- **Canadian Occupational Performance Measure** _(time frame: Baseline and no more than one week post intervention period)_
- **Motor Activity Log** _(time frame: Baseline and no more than one week post intervention period)_
- **Western Aphasia Battery - Revised** _(time frame: Baseline)_
- **Cognitive Linguistic Quick Test** _(time frame: Baseline)_

## Locations (1)

- Duquesne University Speech, Hearing, Language Clinic, Pittsburgh, Pennsylvania, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.duquesne university speech, hearing, language clinic|pittsburgh|pennsylvania|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT02906956.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT02906956*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*